Your browser doesn't support javascript.
loading
m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma.
Chen, Lianze; Hu, Baohui; Song, Xinyue; Wang, Lin; Ju, Mingyi; Li, Zinan; Zhou, Chenyi; Zhang, Ming; Wei, Qian; Guan, Qiutong; Jiang, Longyang; Chen, Ting; Wei, Minjie; Zhao, Lin.
Afiliação
  • Chen L; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Hu B; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Song X; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Wang L; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Ju M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Li Z; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Zhou C; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Zhang M; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Wei Q; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Guan Q; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Jiang L; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Chen T; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
  • Wei M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Zhao L; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Sheny
Front Oncol ; 11: 598017, 2021.
Article em En | MEDLINE | ID: mdl-33796449
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article